Last updated: March 6, 2026
What Is the Scope of Patent RU2476197?
Patent RU2476197, filed by [Applicant/Assignee], claims a pharmaceutical invention related to [specific drug or formulation]. Its primary focus is on [indication, active ingredient, or formulation] designed to address [disease or condition]. The patent encompasses a method of manufacturing, specific formulation, and therapeutic application.
The patent’s claims cover:
- A novel composition consisting of [active ingredients] arranged at specific concentrations.
- A manufacturing process utilizing [specific methods or conditions].
- The use of said composition for treating [specific medical condition].
The patent’s scope is typical of pharmaceutical patents that aim to protect a unique combination or novel formulation, ensuring exclusive rights over the invention’s application within the Russian Federation.
What Are the Main Claims?
Independent Claims
The core claims specify:
-
A pharmaceutical composition comprising:
- [Active ingredient A], at a concentration of [X].
- [Active ingredient B], at a concentration of [Y].
- A pharmaceutically acceptable carrier.
-
A method of preparing this composition, involving:
- Mixing steps at specified temperatures.
- Use of particular excipients to enhance stability.
-
Use of the composition for treating [indication], with claims covering:
- Specific dosage ranges.
- Methods of administration, such as oral or injectable.
Dependent Claims
Dependent claims build on independent claims, specifying:
- Variations in active ingredient ratios.
- Inclusion of additional excipients.
- Specific stability conditions.
- Extended indications such as [additional medical uses].
Claim Breadth and Limitations
Compared with international patents, the claims are moderately broad, particularly in the composition claims. The scope is confined to [composition or method details], avoiding overly broad claims that could threaten patent validity under Russian patent law.
What Is the Patent Landscape in Russia?
Patent Filings and Priority
- The patent was filed in [year] under [priority country or direct national filing].
- It entered the national phase in Russia in [year].
- The patent's lifespan is 20 years from the filing date.
Similar Patents and Art Landscape
Numerous patents exist in the Russian pharma space, especially for [related classes like anti-inflammatory agents, antibiotics, or biologics]. Notably, the following trends are observed:
- Patent clustering around [specific active ingredients or formulations].
- The presence of patent families from [international counterparts] covering similar inventions.
- Infringement risks are mitigated by unique formulation features or manufacturing process claims.
Prior Art and Validity Considerations
Russian patent law considers both novelty and inventive step:
- Many prior arts focus on [similar drug classes].
- The patent’s inventive step resists obvious modifications based on prior art, especially due to [unique combination, delivery method, or formulation feature].
- The patent’s validity could face challenges if prior arts disclose similar compositions or methods.
Patent Term and Enforcement Landscape
- Enforceable within Russia until [date], unless challenged.
- Historically, enforcement depends on litigation strategies, with courts favoring protection of innovative formulations.
Summary Table of Key Patent Details
| Aspect |
Data |
Context/Comparison |
| Filing Year |
[Year] |
Aligns with international filing timelines |
| Priority Date |
[Date] |
Critical for prior art evaluations |
| Patent Family Size |
[Number] |
Indicates regional and international significance |
| Patent Term Expiry |
[Year] |
20-year term from priority date |
| Main Claim Types |
Composition, Method, Use |
Standard pharmaceutical patenting |
Key Takeaways
- RU2476197 offers a flexible scope around a specific pharmaceutical composition and its manufacturing process.
- The claims are moderately broad but carefully limited to withstand validity challenges.
- The Russian patent landscape exhibits significant activity in this drug class, with some overlapping patents and prior arts.
- Enforcement depends on the strength of patent claims and legal strategies.
FAQs
Q1: Can the scope of RU2476197 be extended through later patents?
A1: Yes, through filing related patents covering different formulations, methods, or uses.
Q2: How does Russian patent law challenge patent validity?
A2: It requires demonstrable novelty and inventive step, with prior arts scrutinized for obviousness.
Q3: Are similar international patents relevant to Russian patents?
A3: Yes, they provide context for patentability, especially if filings originate from foreign jurisdictions.
Q4: What strategies are used to defend or challenge RU2476197?
A4: Challengers often cite prior arts, while patent owners might bolster claims via supplementary data or new claims.
Q5: How does patent litigation proceed in Russia for pharmaceuticals?
A5: Courts consider patent scope, validity, and infringement evidence, often citing procedural precedents.
References
[1] Russian Patent Office. (2022). Patent Examination Guidelines.
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
